Jeffrey M. Dayno, Chief Medical Officer at Harmony Biosciences Holdings, Inc. (HRMY), sold 36,400 shares at $43.77 ($1.6M) on 2021-10-19, disclosed to the SEC on 2021-10-20.
Open-market sale of $1.6M HRMY by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.13 | 14,099 | $608K | 38.6% |
| 2 | $43.13 | 14,099 | $608K | 38.6% |
| 3 | $43.77 | 4,101 | $180K | 11.4% |
| 4 | $43.77 | 4,101 | $180K | 11.4% |
| Total | $43.27 avg | 36,400 | $1.6M | 100% |
| Filing → |
| HRMY | SELL | 2022-11-04 | $900K | — | Filing → |
| HRMY | SELL | 2022-11-02 | $827K | — | Filing → |
| HRMY | SELL | 2021-10-07 | $72K | — | Filing → |